127
Views
1
CrossRef citations to date
0
Altmetric
Articles

Association of fractional exhaled nitric oxide with asthma morbidity in urban minority children

, MDORCID Icon, , MD, ScD, , MD & , MBBS, MSORCID Icon
Pages 553-564 | Received 23 Nov 2021, Accepted 30 Apr 2022, Published online: 15 May 2022

References

  • CDC National Center for Health Statistics. National Health Interview Survey (NHIS). National Surveillance of Asthma: United States, 2001–2017.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205.
  • Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin A-C, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST.
  • Pignatti P, Visca D, Loukides S, Märtson A-G, Alffenaar J-WC, Migliori GB, Spanevello A. A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries. Pulmonology. 2022;28(1):44–58. doi:10.1016/j.pulmoe.2020.10.016.
  • Wang Z, Pianosi P, Keogh K, Zaiem F, Alsawas M, Alahdab F, Almasri JM, Mohammed K, Larrea-Mantilla L, Farah W, et al. The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Comparative Effectiveness Review No. 197 (Prepared by the Mayo Clinic Evidence-based Practice Center under Contract No. 290-2015-00013-I). AHRQ Publication No.17(18)-EHC030-EF. Rockville, MD: Agency for Healthcare Research and Quality. 2017. https://www.effectivehealthcare.ahrq.gov/reports/final.cfm
  • National Heart, Lung, and Blood Institute. Focused updates to the asthma management guidelines: a report from the national asthma education and prevention program coordinating committee expert panel working group. J Allergy Clin Immunol. 2020;146(6):1217–1270.
  • Lo D, Beardsmore C, Roland D, Richardson M, Yang Y, Danvers L, Wilson A, Gaillard EA. Risk factors for asthma attacks and poor control in children: a prospective observational study in UK primary care. Arch Dis Child. 2022;107(1):26–31. doi:10.1136/archdischild-2020-320110.
  • Hauerslev M, Garpvall K, Marckmann M, Hermansen MN, Hansen KS, Chawes BL. Long-term predictors of loss of asthma control in school-aged well-controlled children with mild to moderate asthma: a 5-year follow-up. Pediatr Pulmonol. 2022;57(1):81–89. doi:10.1002/ppul.25710.
  • Hahn YS. Measurements of fractional exhaled nitric oxide in pediatric asthma. Korean J Pediatr. 2013;56(10):424–430. doi:10.3345/kjp.2013.56.10.424.
  • Yao T-C, Ou L-S, Lee W-I, Yeh K-W, Chen L-C, Huang J-L. Exhaled nitric oxide discriminates children with and without allergic sensitization in a population-based study. Clin Exp Allergy. 2011;41(4):556–564. doi:10.1111/j.1365-2222.2010.03687.x.
  • Baptist AP, Li L, Dichiaro CA. The importance of atopy on exhaled nitric oxide levels in African American children. Ann Allergy Asthma Immunol. 2015;114(5):399–403. doi:10.1016/j.anai.2015.02.005.
  • Brody DJ, Zhang X, Kit BK, Dillon CF. Reference values and factors associated with exhaled nitric oxide: U.S. youth and adults. Respir Med. 2013;107(11):1682–1691. doi:10.1016/j.rmed.2013.07.006.
  • Linn WS, Rappaport EB, Berhane KT, Bastain TM, Avol EL, Gilliland FD. Exhaled nitric oxide in a population-based study of southern California schoolchildren. Respir Res. 2009;10:28. doi:10.1186/1465-9921-10-28.
  • Kovesi T, Kulka R, Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest. 2008;133(1):169–175. doi:10.1378/chest.07-1177.
  • Wang D, Wang Y, Liang H, David JE, Bray CL. Race and ethnicity have significant influence on fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2018;120(3):272–277. e271. doi:10.1016/j.anai.2017.11.021.
  • Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O’Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008;372(9643):1065–1072. doi:10.1016/S0140-6736(08)61448-8.
  • McCormack MC, Aloe C, Curtin-Brosnan J, Diette GB, Breysse PN, Matsui EC. Guideline-recommended fractional exhaled nitric oxide is a poor predictor of health-care use among inner-city children and adolescents receiving usual asthma care. Chest. 2013;144(3):923–929. doi:10.1378/chest.12-3098.
  • Zhang Y, Berhane K, Eckel SP, Salam MT, Linn WS, Rappaport EB, Bastain TM, Gilliland FD. Determinants of children’s exhaled nitric oxide: new insights from quantile regression. PLoS ONE. 2015;10(7):e0130505. doi:10.1371/journal.pone.0130505.
  • Nguyen DT, Kit BK, Brody D, Akinbami LJ. Prevalence of high fractional exhaled nitric oxide among US youth with asthma. Pediatr Pulmonol. 2017;52(6):737–745. doi:10.1002/ppul.23672.
  • <Network - 2014 - British guideline on the management of asthma.pdf>.
  • National Institute for Health and Care Excellence (UK). Asthma: diagnosis and monitoring of asthma in adults, children and young people. London: National Institute for Health and Care Excellence (UK); 2017. Nov. (NICE Guideline, No. 80.1.). Available from: https://www.ncbi.nlm.nih.gov/books/NBK469773/.
  • Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST.
  • Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CPM, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–522. doi:10.1183/09031936.05.00035005.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108.
  • Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J. 1995;8(3):492–506. doi:10.1183/09031936.95.08030492.
  • Ruppel G. Manual of pulmonary function testing. 9th ed. St Louis, MO: Mosby/Elsievier; 2009.
  • Dubin N, Pasternack BS. Risk assessment for case-control subgroups by polychotomous logistic regression. Am J Epidemiol. 1986;123(6):1101–1117. doi:10.1093/oxfordjournals.aje.a114338.
  • Lo DK, Beardsmore CS, Roland D, Richardson M, Yang Y, Danvers L, Wilson A, Gaillard EA. Lung function and asthma control in school-age children managed in UK primary care: a cohort study. Thorax. 2020;75(2):101–107. doi:10.1136/thoraxjnl-2019-213068.
  • Gemicioglu B, Musellim B, Dogan I, Guven K. Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes. Allergy Rhinol (Providence). 2014;5(3):157–161.
  • Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006;129(6):1492–1499. doi:10.1378/chest.129.6.1492.
  • Heaney LG, Busby J, Bradding P, Chaudhuri R, Mansur AH, Niven R, Pavord ID, Lindsay JT, Costello RW. Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma. Am J Respir Crit Care Med. 2019;199(4):454–464. doi:10.1164/rccm.201806-1182OC.
  • Wang X, Tan X, Li Q. Effectiveness of fractional exhaled nitric oxide for asthma management in children: a systematic review and meta-analysis. Pediatr Pulmonol. 2020;55(8):1936–1945. doi:10.1002/ppul.24898.
  • Buendia JA, Acuna-Cordero R, Rodriguez-Martinez CE. Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma. Cost Eff Resour Alloc. 2021;19(1):33. doi:10.1186/s12962-021-00287-3.
  • Buendia JA, Acuna-Cordero R, Rodriguez-Martinez CE. Budget impact analysis of Fractional Exhaled Nitric Oxide Monitoring for the Management of Childhood Asthma: The Colombian National Health System perspective. J Investig Allergol Clin Immunol. 2021;32(2):0. doi:10.18176/jiaci.0690.
  • Salviano L, Taglia-Ferre KD, Lisboa S, Costa A, Campos HDS, March MFP. Association between fraction of exhaled nitric oxide and spirometry data and clinical control of asthma in children and adolescents. Rev Paul Pediatr. 2018;36(1):8.
  • Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Togawa R, Sato Y, Nikaido T, Wang X, Tanino Y, et al. The clinical role of fractional exhaled nitric oxide in asthma control. Ann Allergy Asthma Immunol. 2017;119(6):541–547. doi:10.1016/j.anai.2017.09.059.
  • Duijts L, Granell R, Sterne JA, Henderson AJ. Childhood wheezing phenotypes influence asthma, lung function and exhaled nitric oxide fraction in adolescence. Eur Respir J. 2016;47(2):510–519. doi:10.1183/13993003.00718-2015.
  • Pifferi M, Bush A, Pioggia G, Di Cicco M, Chinellato I, Bodini A, Macchia P, Boner AL. Monitoring asthma control in children with allergies by soft computing of lung function and exhaled nitric oxide. Chest. 2011;139(2):319–327. doi:10.1378/chest.10-0992.
  • van Dalen C, Harding E, Parkin J, Cheng S, Pearce N, Douwes J. Suitability of forced expiratory volume in 1 second/forced vital capacity vs percentage of predicted forced expiratory volume in 1 second for the classification of asthma severity in adolescents. Arch Pediatr Adolesc Med. 2008;162(12):1169–1174. doi:10.1001/archpedi.162.12.1169.
  • Nordvall SL, Janson C, Kalm-Stephens P, Foucard T, Toren K, Alving K. Exhaled nitric oxide in a population-based study of asthma and allergy in schoolchildren. Allergy. 2005;60(4):469–475. doi:10.1111/j.1398-9995.2005.00735.x.
  • Fielding S, Pijnenburg M, de Jongste JC, Pike KC, Roberts G, Petsky H, Chang AB, Fritsch M, Frischer T, Szefler S, et al. Change in FEV1 and feno measurements as predictors of future asthma outcomes in children. Chest. 2019;155(2):331–341. doi:10.1016/j.chest.2018.10.009.
  • Gorlanova O, Appenzeller R, Mahmoud YS, et al. Effect of breastfeeding duration on lung function, respiratory symptoms and allergic diseases in school-age children. Pediatr Pulmonol. 2020;55(6):1448–1455. doi:10.1002/ppul.24733.
  • Trischler J, Müller C-M, Könitzer S, Prell E, Korten I, Unverzagt S, Lex C. Elevated exhaled leukotriene B(4) in the small airway compartment in children with asthma. Ann Allergy Asthma Immunol. 2015;114(2):111–116. doi:10.1016/j.anai.2014.11.022.
  • Korten I, Zacharasiewicz A, Bittkowski N, Hofmann A, Lex C. Asthma control in children: body plethysmography in addition to spirometry. Pediatr Pulmonol. 2019;54(8):1141–1148. doi:10.1002/ppul.24320.
  • Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG, Severe Asthma Research Program, and National Institutes of Health. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol. 2006;118(6):1218–1225. doi:10.1016/j.jaci.2006.08.019.
  • Han YY, Forno E, Celedón JC. Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children. Am J Respir Crit Care Med. 2014;190(1):32–39. doi:10.1164/rccm.201403-0565OC.
  • Zhang Y, Chen Z, Berhane K, Urman R, Chatzi VL, Breton C, Gilliland FD. The dynamic relationship between asthma and obesity in schoolchildren. Am J Epidemiol. 2020;189(6):583–591. doi:10.1093/aje/kwz257.
  • Gilliland FD, Berhane K, Islam T, McConnell R, Gauderman WJ, Gilliland SS, Avol E, Peters JM. Obesity and the risk of newly diagnosed asthma in school-age children. Am J Epidemiol. 2003;158(5):406–415. doi:10.1093/aje/kwg175.
  • Morphew T, Shin HW, Marchese S, Pires-Barracosa N, Galant SP. Phenotypes favoring fractional exhaled nitric oxide discordance vs guideline-based uncontrolled asthma. Ann Allergy Asthma Immunol. 2019;123(2):193–200. doi:10.1016/j.anai.2019.05.008.
  • Cabrejos S, Moreira A, Ramirez A, Quirce S, Soto Campos G, Dávila I, Campo P. FENOMA study: achieving full control in patients with severe allergic asthma. J Asthma Allergy. 2020;13:159–166. doi:10.2147/JAA.S246902.
  • Schleich FN, Seidel L, Sele J, Manise M, Quaedvlieg V, Michils A, Louis R. Exhaled nitric oxide thresholds associated with a sputum eosinophil count >/=3% in a cohort of unselected patients with asthma. Thorax. 2010;65(12):1039–1044. doi:10.1136/thx.2009.124925.
  • De Keyser HEH, Kaye L, Anderson WC, Gondalia R, Theye B, Szefler SJ, Stempel DA. Electronic medication monitors help determine adherence subgroups in asthma. Respir Med. 2020;164:105914. doi:10.1016/j.rmed.2020.105914.
  • Comberiati P, Peroni D, Malka-Rais J, Morganti R, Spahn JD. Fractional exhaled nitric oxide response to oral corticosteroids in children with mild-to-moderate asthma: influence of race. Ann Allergy Asthma Immunol. 2020;125(4):440–446. doi:10.1016/j.anai.2020.06.036.
  • Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax. 2002;57(10):889–896. doi:10.1136/thorax.57.10.889.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.